News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,463 Results
Type
Article (41254)
Company Profile (262)
Press Release (661947)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (205616)
Career Advice (2020)
Deals (35587)
Drug Delivery (99)
Drug Development (81577)
Employer Resources (172)
FDA (16328)
Job Trends (14938)
News (347674)
Policy (32998)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2599)
Accelerated approval (5)
Adcomms (21)
Allergies (85)
Alliances (50113)
ALS (87)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (114)
Approvals (16320)
Artificial intelligence (247)
Autoimmune disease (21)
Automation (15)
Bankruptcy (362)
Best Places to Work (11685)
BIOSECURE Act (20)
Biosimilars (110)
Biotechnology (186)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (264)
Cancer (2106)
Cardiovascular disease (168)
Career advice (1685)
Career pathing (29)
CAR-T (145)
Cell therapy (414)
Cervical cancer (19)
Clinical research (66196)
Collaboration (806)
Compensation (508)
Complete response letters (21)
COVID-19 (2627)
CRISPR (38)
C-suite (226)
Cystic fibrosis (101)
Data (2058)
Decentralized trials (2)
Denatured (19)
Depression (40)
Diabetes (258)
Diagnostics (6383)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (86529)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112640)
Executive appointments (695)
FDA (17523)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (726)
Gene editing (102)
Generative AI (20)
Gene therapy (296)
GLP-1 (707)
Government (4510)
Grass and pollen (4)
Guidances (51)
Healthcare (18894)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (116)
Indications (27)
Infectious disease (2770)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (91)
Interviews (312)
IPO (16560)
IRA (41)
Job creations (3669)
Job search strategy (1433)
Kidney cancer (9)
Labor market (36)
Layoffs (467)
Leadership (16)
Legal (7967)
Liver cancer (73)
Lung cancer (307)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (291)
MASH (62)
Medical device (13414)
Medtech (13419)
Mergers & acquisitions (19542)
Metabolic disorders (659)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (87)
Neuropsychiatric disorders (24)
Neuroscience (1893)
NextGen: Class of 2025 (6562)
Non-profit (4505)
Northern California (2538)
Now hiring (38)
Obesity (355)
Opinion (211)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (22)
Patents (225)
Patient recruitment (100)
Peanut (49)
People (57599)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20643)
Phase II (29125)
Phase III (21741)
Pipeline (1121)
Policy (135)
Postmarket research (2578)
Preclinical (8750)
Press Release (71)
Prostate cancer (98)
Psychedelics (31)
Radiopharmaceuticals (244)
Rare diseases (380)
Real estate (5996)
Recruiting (65)
Regulatory (22554)
Reports (46)
Research institute (2358)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (43)
Schizophrenia (67)
Series A (126)
Series B (82)
Service/supplier (11)
Sickle cell disease (54)
Southern California (2193)
Special edition (14)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3626)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (25)
The Weekly (30)
United States (22137)
Vaccines (695)
Venture capitalists (38)
Weight loss (230)
Women's health (34)
Worklife (15)
Date
Today (34)
Last 7 days (484)
Last 30 days (2393)
Last 365 days (33129)
2025 (9281)
2024 (35480)
2023 (40334)
2022 (51487)
2021 (56038)
2020 (54404)
2019 (46849)
2018 (35303)
2017 (32485)
2016 (31855)
2015 (37923)
2014 (31692)
2013 (26709)
2012 (28881)
2011 (29574)
2010 (27569)
Location
Africa (732)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (38453)
Australia (6263)
California (5804)
Canada (1942)
China (495)
Colorado (255)
Connecticut (263)
Delaware (135)
Europe (82642)
Florida (861)
Georgia (202)
Idaho (57)
Illinois (514)
India (25)
Indiana (302)
Iowa (9)
Japan (149)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (881)
Massachusetts (4365)
Michigan (215)
Minnesota (386)
Mississippi (2)
Missouri (79)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1671)
New Mexico (28)
New York (1657)
North Carolina (942)
North Dakota (8)
Northern California (2538)
Ohio (197)
Oklahoma (14)
Oregon (34)
Pennsylvania (1306)
Puerto Rico (11)
Rhode Island (30)
South America (1112)
South Carolina (20)
South Dakota (1)
Southern California (2193)
Tennessee (99)
Texas (862)
Utah (173)
Virginia (136)
Washington D.C. (60)
Washington State (532)
West Virginia (3)
Wisconsin (51)
703,463 Results for "abcellera biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbCellera to Participate at Upcoming Investor Conferences in May and June
April 8, 2025
·
1 min read
Press Releases
AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
April 4, 2025
·
1 min read
Press Releases
AbCellera Reports Full Year 2024 Business Results
February 27, 2025
·
12 min read
Press Releases
AbCellera to Participate at Upcoming Investor Conferences in March 2025
February 12, 2025
·
1 min read
Press Releases
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
March 25, 2025
·
3 min read
Press Releases
AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
January 21, 2025
·
1 min read
Press Releases
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
January 13, 2025
·
3 min read
Business
AbCellera Reports Q1 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024.
May 7, 2024
·
12 min read
Press Releases
AbCellera to Present at Upcoming Investor Conferences in December and January
November 22, 2024
·
1 min read
Business
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
June 25, 2024
·
1 min read
1 of 70,347
Next
